89 COST-EFFECTIVENESS AND FINANCIAL IMPACT OF BOTULINUM TOXIN TYPE A TREATMENT FOR URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY IN MULTIPLE SCLEROSIS PATIENTS WITHIN THE FRENCH HEALTHCARE SYSTEM

J.D. Campbell; V.D. Patel; P. Denys; E. Chartier-Kastler; E. Hayward

doi:10.1016/s1569-9056(10)60095-4

89 COST-EFFECTIVENESS AND FINANCIAL IMPACT OF BOTULINUM TOXIN TYPE A TREATMENT FOR URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY IN MULTIPLE SCLEROSIS PATIENTS WITHIN THE FRENCH HEALTHCARE SYSTEM

European Urology Supplements ◽

10.1016/s1569-9056(10)60095-4 ◽

2010 ◽

Vol 9 (2) ◽

pp. 60-61 ◽

Cited By ~ 1

Author(s):

J.D. Campbell ◽

V.D. Patel ◽

P. Denys ◽

E. Chartier-Kastler ◽

E. Hayward

Keyword(s):

Multiple Sclerosis ◽

Urinary Incontinence ◽

Botulinum Toxin ◽

Cost Effectiveness ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Botulinum Toxin Type ◽

Financial Impact ◽

Neurogenic Detrusor Overactivity ◽

Multiple Sclerosis Patients

Download Full-text

PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

Value in Health ◽

10.1016/j.jval.2012.08.434 ◽

2012 ◽

Vol 15 (7) ◽

pp. A676

Author(s):

J.T. Tan ◽

M. Frost ◽

K. Ng ◽

M. Kirchmann

Keyword(s):

Urinary Incontinence ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Neurogenic Detrusor Overactivity ◽

Cost Reductions

Download Full-text

Efficacy and safety of onabotulinumtoxina 100 U for treatment of urinary incontinence due to neurogenic detrusor overactivity in noncatheterizing multiple sclerosis patients

Toxicon ◽

10.1016/j.toxicon.2016.11.059 ◽

2016 ◽

Vol 123 ◽

pp. S19

Author(s):

Francisco Cruz ◽

Pierre Denys ◽

Veronique Keppenne ◽

Alfred Kohan ◽

Benjamin Brucker ◽

...

Keyword(s):

Multiple Sclerosis ◽

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Multiple Sclerosis Patients

Download Full-text

Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia

The Journal of Urology ◽

10.1016/j.juro.2018.06.065 ◽

2019 ◽

Vol 201 (1) ◽

pp. 174-181 ◽

Cited By ~ 3

Author(s):

Cagri Akin Sekerci ◽

Yiloren Tanidir ◽

Tuncay Toprak ◽

Banu Isbilen Basok ◽

Ferruh Isman ◽

...

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Neurotrophic Factor ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Brain Derived Neurotrophic Factor ◽

Neurogenic Detrusor Overactivity

Download Full-text

Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport®) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity

International Urology and Nephrology ◽

10.1007/s11255-009-9528-y ◽

2009 ◽

Vol 41 (4) ◽

pp. 805-813 ◽

Cited By ~ 17

Author(s):

Ibrahim Fathi Ghalayini ◽

Mohammed A. Al-Ghazo ◽

Ziad Ali Elnasser

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Drug Resistant ◽

Neurogenic Detrusor Overactivity ◽

Dose Dependent

Download Full-text

Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results after Five Injections in Patients with Neurogenic Detrusor Overactivity

European Urology ◽

10.1016/j.eururo.2007.08.052 ◽

2007 ◽

Vol 52 (6) ◽

pp. 1729-1735 ◽

Cited By ~ 76

Author(s):

André Reitz ◽

Pierre Denys ◽

Christophe Fermanian ◽

Brigitte Schurch ◽

Eva Comperat ◽

...

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Neurogenic Detrusor Overactivity

Download Full-text

Efficacy and Tolerability of Botulinum Toxin Type A in Patients with Neurogenic Detrusor Overactivity and Without Concomitant Anticholinergic Therapy: Comparison of Two Doses

European Urology ◽

10.1016/j.eururo.2010.06.035 ◽

2010 ◽

Vol 58 (5) ◽

pp. 759-766 ◽

Cited By ~ 33

Author(s):

Philippe Grise ◽

Alain Ruffion ◽

Pierre Denys ◽

Guy Egon ◽

Emmanuel Chartier Kastler

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Neurogenic Detrusor Overactivity ◽

Anticholinergic Therapy

Download Full-text

647 Efficacy and safety of onabotulinumtoxinA 100U for treatment of urinary incontinence due to neurogenic detrusor overactivity in non-catheterising multiple sclerosis patients

European Urology Supplements ◽

10.1016/s1569-9056(16)60649-8 ◽

2016 ◽

Vol 15 (3) ◽

pp. e647 ◽

Cited By ~ 1

Author(s):

E. Chartier-Kastler ◽

P. Denys ◽

V. Keppenne ◽

B. Brucker ◽

B. Egerdie ◽

...

Keyword(s):

Multiple Sclerosis ◽

Urinary Incontinence ◽

Detrusor Overactivity ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Multiple Sclerosis Patients

Download Full-text

A comparative study between treatment with oxybutynin and botulinum toxin type A in patients with neurogenic detrusor overactivity

http://isrctn.org/> ◽

10.1186/isrctn56769820 ◽

2012 ◽

Author(s):

Ruiter Silva Ferreira

Keyword(s):

Botulinum Toxin ◽

Comparative Study ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Neurogenic Detrusor Overactivity

Download Full-text

Botulinum Toxin Type A Injections for Treating Neurogenic Detrusor Overactivity Combined With Low-Compliance Bladder in Patients With Spinal Cord Lesions

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2005.06.008 ◽

2005 ◽

Vol 86 (11) ◽

pp. 2114-2118 ◽

Cited By ~ 51

Author(s):

Jakkrit Klaphajone ◽

Wasuwat Kitisomprayoonkul ◽

Supon Sriplakit

Keyword(s):

Spinal Cord ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Neurogenic Detrusor Overactivity ◽

Spinal Cord Lesions

Download Full-text

Cost-Effectiveness Comparison Of Botulinum Toxin Type A Plus Best Supportive Care Versus Best Supportive Care Alone In The Treatment Of Idiopathic Overactive Bladder With Urinary Incontinence Among Patients Not Adequately Managed By Anticholinergic Therapy In France

Value in Health ◽

10.1016/j.jval.2014.08.1330 ◽

2014 ◽

Vol 17 (7) ◽

pp. A470 ◽

Cited By ~ 1

Author(s):

A. Ruffion ◽

M. Velard ◽

C. Loveman ◽

K. Khalaf ◽

S. Roze ◽

...

Keyword(s):

Urinary Incontinence ◽

Botulinum Toxin ◽

Cost Effectiveness ◽

Overactive Bladder ◽

Supportive Care ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Best Supportive Care ◽

Anticholinergic Therapy

Download Full-text